Blanket bans fail to regulate biotech
NPA, 7-4-2021, NATO Parliamentary Assembly https://www.nato-pa.int/news/virtual-visit-france-nato-parliamentarians-discuss-space-security-biotech-advances-and-nato-st, "NATO PA," In virtual visit to France, NATO Parliamentarians discuss space security, biotech advances and NATO S&T cooperation | NATO PA (ermo/sms, Acc:7-3-2022)
lisande Nexon, Senior Research Fellow at the French Foundation for Strategic Research (FRS), noted that the international community has witnessed how biotechnology can help address healthcare issues in the context of COVID-19. Similar impacts, she argued, could be seen in areas like agriculture, environmental industries, or the materials industry. Still, she said, the stakes are high, as there are a variety of risks inherent in biotechnology, including laboratory leaks, environmental spill over effects and ethical issues.
Both experts cautioned against a blanket approach to the banning of certain biotechnologies or the prevention of their development as a whole. An appropriate approach would instead be to focus on legislation and multilateral cooperation**,** the Committee was informed. Ms Nexon emphasised that “we need to promote international cooperation and information exchange,” adding that difficulties exist because, “there are significant differences between states – whether national interests, regulations, views on [human rights], and financial resources.” The promotion of information exchanges, emphasis on improved transparency, and a general effort to raise awareness with the public of potential risks inherent in biotechnologies are all valid lines of action, she argued. To that end, NATO Allies should “train, regulate and encourage scientists to adhere to these approaches, and to evaluate risks and threats regularly with academia and scientists. It is important that we are able to recognise whether [an incident related to biotechnology] was accidental or deliberate, and whether we can attribute responsibility to a human actor […].”